KPMG at the 42nd Annual J.P. Morgan Healthcare Conference 2024

This year KPMG will be hosting a series of events to coincide with the 42nd Annual J.P. Morgan Healthcare Conference. Hear from leading industry luminaries, emerging fast-growth companies, innovative technology creators, and members of the investment community, and get forward-thinking perspectives and insights on key life sciences and healthcare topics.

If you are planning on being in San Francisco for the J.P. Morgan Healthcare Conference, we want to see you!

Add KPMG to your agenda:

• January 9, 2024 – Healthcare Executive Panel Series: Join KPMG and healthcare industry leaders for a series of panels to discuss market themes, deal trends, role of innovation and AI, and outlook for 2024.
• January 10, 2024 – Goodwin + KPMG @ JP Morgan Symposium: Life sciences companies have many opportunities to thrive in the face of changing tides. At this year's symposium, we will delve into strategies that enable them to enhance research and development; optimize value from licensing, M&A, and other transactions; and secure capital for growth. By embracing these opportunities, life sciences companies can not only avoid getting caught in a riptide but chart new paths to success.

Register for Tuesday, January 9 – Healthcare Panel Series

Register for Wednesday, January 10 – Goodwin + KPMG @ JPMorgan Symposium

Additional details on these events can be found below.

January 9-10, 2024

January 9, 2024 | Healthcare Executive Panel Series

Join KPMG and healthcare industry leaders for a series of panels to discuss market themes, deal trends, role of innovation and AI, and outlook for 2024. 

There will be three panels. 

2:00 Panel: Navigating Complex Healthcare Transactions in a Challenging Deal Market. The deal market has been faced with challenges in bid-ask spreads, rising interest rates, inflationary pressures, and geopolitical problems. Successful deal-makers have had to navigate these numerous challenges to create value and deploy capital in executing complex transactions and deal structures. 

• Moderators: Ross Nelson, MD, KPMG Principal, National Healthcare Strategy Leader and Brett Bell, KPMG Partner, Financial Due Diligence 
• Panelists:
  • Geoff Tresley, Principal, GTCR LLC
  • Feby Abraham, Executive Vice President, Chief Strategy and Innovations Officer, Memorial Hermann Health System 
  • John Jones, Partner, Co-Leader Healthcare Private Equity, Chair Healthcare Regulatory and Compliance, Goodwin

3:00 Panel:  Pushing Forward While Catching Up: Innovation and AI in Healthcare – As underlying healthcare costs rise at the same rate or faster than revenues for many healthcare providers, these providers and other ecosystem players are working feverishly both to incorporate AI and other innovative technology to manage costs and increase standardization and to accelerate innovation to drive existing and new streams of revenue.

• Moderator:  Ash Shehata, KPMG Partner, National Healthcare Sector Leader
• Panelists:
  • Leigh Anderson, Chief Operating Officer, Premier
  • Hannah Koczka, Vice President, Northwestern

4:00 Panel:  Planning for Regulatory and Policy Uncertainty: While the market has been inconsistent, regulatory agendas have continued to develop and will impact Healthcare M&A during 2024.

• Moderator:  Brett Glover, KPMG Healthcare and Life Sciences Deal Advisory and Strategy Partner
• Panelists:
  • Jaime Pego, KPMG Principal, Healthcare Forensics 
  • Dennis Williams, JD, RN, Corporate Healthcare Partner, Kirkland and Ellis
  • Zach Gaumer, Principal, Health Management Associates 

Date: Tuesday, January 9, 2024

Time: 2:00 p.m.–5:00 p.m.

Location: KPMG in San Francisco, 55 Second Street, 11th Floor, San Francisco, CA 94105

Register for Tuesday, January 9 – Healthcare Panel Series

Register for Wednesday, January 10 – Goodwin + KPMG @ JPMorgan Symposium

January 10, 2024 | Goodwin + KPMG @ JPMorgan Symposium

Life sciences companies have many opportunities to thrive in the face of changing tides. At this year's symposium, we will delve into strategies that enable them to enhance research and development; optimize value from licensing, M&A, and other transactions; and secure capital for growth. By embracing these opportunities, life sciences companies can not only avoid getting caught in a riptide but chart new paths to success.

Date: Wednesday, January 10, 2024

Time: 8:30 a.m.-6:30 p.m. PST

Location: InterContinental San Francisco, 888 Howard Street, 5th Floor, InterContinental Ballroom, San Francisco, CA 94103

Goodwin and KPMG are pleased to invite you to our 5th Annual Symposium, to be held during the 42nd Annual JP Morgan Healthcare Conference week.

Amid the dynamic shifts in the life sciences and healthcare sectors, there are ample opportunities for companies to succeed. At this year’s conference, you will have the opportunity to hear from leading strategic, legal, and financial experts as they collaborate with industry luminaries to unveil a diverse range of topics in life sciences and healthcare. The conference will traverse the continuum from early-stage investment principles through successful collaboration agreements and mergers and acquisitions, as well as navigating capital markets, to panels exploring new paradigms in private equity healthcare investing and the new era of global precision medicine. The program will also provide insights into the complexities of the Inflation Reduction Act, as well as discussions on strategies for resilience and successful navigation of the challenges faced by public companies in these sectors.

Please continue to check out our website as we build out the agenda topics for the day.  

We look forward to seeing you in San Francisco!

Goodwin + KPMG @ JPMorgan Symposium

Full Agenda (all times Pacific)

We hope you can join us!

Register for Tuesday, January 9 – Healthcare Panel Series

Register for Wednesday, January 10 – Goodwin + KPMG @ JPMorgan Symposium